Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$90,892,028
-$2,299,255 QoQ
Shares Held
719,424
+7.6% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#157
of 2,284 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $3,769,908,119 across 17 Drug Manufacturers - General names. GILD ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,750,788 | $2,099,947,825 | |
| 2 | ABBV |
AbbVie Inc.
|
2,151,394 | $541,376,786 | |
| 3 | JNJ |
Johnson & Johnson
|
1,943,962 | $493,708,029 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,500,619 | $192,829,541 | |
| 5 | AMGN |
Amgen Inc
|
438,431 | $158,764,633 | |
| 6 | PFE |
Pfizer Inc
|
4,509,295 | $108,583,823 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
719,424 | $90,892,028 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,140,161 | $65,696,076 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,892,028 | 719,424 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $93,191,283 | 668,661 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $54,269,613 | 442,151 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $43,685,715 | 393,565 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $42,011,193 | 378,923 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $41,357,767 | 369,101 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $27,073,092 | 293,094 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $24,621,125 | 293,668 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $20,402,075 | 297,363 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $23,430,404 | 319,869 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $26,341,211 | 325,160 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $24,628,281 | 328,640 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $26,249,271 | 340,590 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $28,834,978 | 347,535 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $31,629,200 | 368,424 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $23,187,975 | 375,879 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $22,826,247 | 369,297 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $22,772,560 | 383,054 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $29,036,303 | 399,894 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $28,153,880 | 403,062 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $26,953,525 | 391,425 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $26,761,020 | 414,065 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $24,578,262 | 421,872 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $32,821,960 | 519,417 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $41,925,837 | 544,916 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $41,841,527 | 559,678 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||